ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Okyo Pharma Limited

Okyo Pharma Limited (OKYO)

91.00
0.00
(0.00%)
終了 11月30日 1:30AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
91.00
買値
1.20
売値
1.60
出来高
0.00
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
91.00
始値
-
時刻
(O)
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

OKYO 最新ニュース

OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference

OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference LONDON and NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage...

OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference

OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference LONDON and NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a...

OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain

OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OK-101 is the first drug candidate to enroll patients specifically diagnosed with...

OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain

OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain Neuropathic corneal pain (NCP) is listed in the National Organization for Rare Disorders...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease

OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease LONDON and NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a...

OKYO Pharma CEO Interview to Air on Bloomberg TV

OKYO Pharma CEO Interview to Air on Bloomberg TV LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TOMTomco Energy Plc
0.07p
(55.56%)
303.8M
WPHOWindar Photonics Plc
49.50p
(23.13%)
375.62k
SALTMicrosalt Plc
85.00p
(21.43%)
75.09k
APQApq Global Limited
6.50p
(18.18%)
308.73k
PIPPipehawk Plc
1.35p
(17.39%)
211.72k
RGTArgent Biopharma Limited
10.50p
(-32.26%)
120.31k
ZNTZentra Group Plc
5.50p
(-21.43%)
40.26k
TRYBTribe Technology Plc
1.90p
(-19.15%)
570k
IMMImmupharma Plc
1.20p
(-15.79%)
11.99M
IMCImc Exploration Group Plc
0.50p
(-13.04%)
1.4M
ORCPOracle Power Plc
0.031p
(6.90%)
2B
NTVONativo Resources Plc
0.0025p
(0.00%)
1.49B
TRPTower Resources Plc
0.031p
(6.90%)
811.74M
PREMPremier African Minerals Limited
0.0545p
(17.20%)
788.95M
MSMNMosman Oil And Gas Limited
0.04p
(5.26%)
565.46M

最近閲覧した銘柄

Delayed Upgrade Clock